Russell Angus C.

1.4

1.4

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Revance Therapeutics Inc (RVNC)

Transaction date 13 Dec 2021

Purchase

Price

397.75

Quantity 41,065 -9.2%

Value US$4,959,926

Comments Filing

Keenova Therapeutics PLC (MCKPF)

Transaction date 12 Nov 2020

Sale

Price

316.47

Quantity 18,881 +32.4%

Value US$2,258,014

Comments Filing

Lineage Cell Therapeutics Inc (LCTX)

Transaction date 6 Nov 2015

Purchase

Price

487.87

Quantity 2,081 -45.1%

Value US$2,403,211

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2021-12-15	2021-12-13	Revance Therapeutics Inc (RVNC)	B Purchase	41,065 -9.2% 397.75 US$4,959,926	41,065 -9.2%	397.75	US$4,959,926
2020-11-16	2020-11-12	Keenova Therapeutics PLC (MCKPF)	S Sale	18,881 +32.4% 316.47 US$2,258,014	18,881 +32.4%	316.47	US$2,258,014
2015-11-10	2015-11-06	Lineage Cell Therapeutics Inc (LCTX)	B Purchase	2,081 -45.1% 487.87 US$2,403,211	2,081 -45.1%	487.87	US$2,403,211